Evelo Biosciences, Inc.
EVLODrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EDP1815 | Phase 2 | Atopic Dermatitis | - | - |
Frequently asked questions
What is in Evelo Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Evelo Biosciences, Inc.'s (EVLO) pipeline across Phase 2. Its lead program is EDP1815 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Evelo Biosciences, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Evelo Biosciences, Inc. (EVLO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EVLO biotech catalysts?→
Add EVLO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Evelo Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.